Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 13

Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice

Total article views   HTML views PDF downloads Totals
8,299 Dovepress* 7,037+ 1,397 8,434
PubMed Central* 1,262 281 1,543
Totals 8,299 1,678 9,977
*Since 17 March 2020
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar